Patent Yard Sign in
Canadian application, no grantCanada

Method of treating sepsis

CA 2287877 A1 · Owner: Smithkline Beecham Corporation · Inventors: Demarsh, Peter Lawrence; Johanson, Kyung O.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to the method of preventing and treating sepsis using chemokines selected from mature or modified KCSEQ ID NO:1 gro.alpha.SEQ ID , NO:2, gro.beta.SEQ ID NO:3 or gro.gamma.SEQ ID NO:4 or multimers thereof alone or in conjunction with an anti-infective agent. This invention also relates to a new gro.beta. dimer chemokine.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 29, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 29, 1998
GrantedNo grant recorded
Term endedApril 29, 2018
Patent numberCA 2287877 A1
Classification (IPC)A61K38/16 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedApril 29, 1998Term endedApril 29, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.